SB 1091 Summary

• Expands access to controlled substances prescription monitoring program data to health care insurers for drug utilization reviews that prevent opioid overuse and ensure care safety and quality.

• Allows health care insurer employees with appropriate licensure to access the program as delegates under the supervision of a chief medical officer or licensed health care professional authorized to prescribe controlled substances.

• Permits licensed health care professionals and chief medical officers to authorize up to ten delegates for program access, with delegates required to hold valid licenses under specified title 32 chapters.

• Establishes that program data cannot be used for credentialing health care professionals, determining payment, or preemployment screening.

• Defines "health care insurer" and adds definitional provisions for "administration" and "contractor" related to Arizona Health Care Cost Containment System administration in the controlled substances monitoring program statutes.